| Long-lasting complete responses in patients with metastatic melanoma after adoptive cell therapy with tumor-infiltrating lymphocytes and an attenuated IL2 regimen R Andersen, M Donia, E Ellebaek, TH Borch, P Kongsted, TZ Iversen, ... Clinical cancer research 22 (15), 3734-3745, 2016 | 355 | 2016 |
| Tumor-infiltrating lymphocyte therapy or ipilimumab in advanced melanoma MW Rohaan, TH Borch, JH Van Den Berg, Ö Met, R Kessels, ... New England journal of medicine 387 (23), 2113-2125, 2022 | 193 | 2022 |
| Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients E Ellebaek, TZ Iversen, N Junker, M Donia, L Engell-Noerregaard, Ö Met, ... Journal of translational medicine 10, 1-12, 2012 | 189 | 2012 |
| Dissection of T-cell antigen specificity in human melanoma RS Andersen, CA Thrue, N Junker, R Lyngaa, M Donia, E Ellebæk, ... Cancer research 72 (7), 1642-1650, 2012 | 189 | 2012 |
| Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial E Ellebaek, L Engell-Noerregaard, TZ Iversen, TM Froesig, S Munir, ... Cancer immunology, immunotherapy 61, 1791-1804, 2012 | 152 | 2012 |
| Characterization and comparison of ‘Standard’and ‘young’Tumour‐Infiltrating lymphocytes for adoptive cell therapy at a Danish Translational research institution M Donia, N Junker, E Ellebaek, MH Andersen, PT Straten, IM Svane Scandinavian journal of immunology 75 (2), 157-167, 2012 | 144 | 2012 |
| Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an epitope derived from indoleamine 2, 3 dioxygenase TZ Iversen, L Engell-Noerregaard, E Ellebaek, R Andersen, SK Larsen, ... Clinical Cancer Research 20 (1), 221-232, 2014 | 134 | 2014 |
| A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma JW Kjeldsen, CL Lorentzen, E Martinenaite, E Ellebaek, M Donia, ... Nature medicine 27 (12), 2212-2223, 2021 | 123 | 2021 |
| Dendritic cell vaccination in combination with docetaxel for patients with metastatic castration-resistant prostate cancer: A randomized phase II study P Kongsted, TH Borch, E Ellebaek, TZ Iversen, R Andersen, Ö Met, ... Cytotherapy 19 (4), 500-513, 2017 | 71 | 2017 |
| Optimal treatment intensity in children with Down syndrome and myeloid leukaemia: data from 56 children treated on NOPHO-AML protocols and a review of the literature L Abildgaard, E Ellebæk, G Gustafsson, J Abrahamsson, L Hovi, ... Annals of hematology 85, 275-280, 2006 | 64 | 2006 |
| The real-world impact of modern treatments on the survival of patients with metastatic melanoma M Donia, E Ellebaek, TH Øllegaard, L Duval, JB Aaby, L Hoejberg, ... European Journal of Cancer 108, 25-32, 2019 | 59 | 2019 |
| Analysis of Vδ1 T cells in clinical grade melanoma-infiltrating lymphocytes M Donia, E Ellebaek, MH Andersen, PT Straten, IM Svane Oncoimmunology 1 (8), 1297-1304, 2012 | 56 | 2012 |
| Methods to improve adoptive T-cell therapy for melanoma: IFN-γ enhances anticancer responses of cell products for infusion M Donia, M Hansen, SL Sendrup, TZ Iversen, E Ellebæk, MH Andersen, ... Journal of Investigative Dermatology 133 (2), 545-552, 2013 | 55 | 2013 |
| Real-world impact of immune checkpoint inhibitors in metastatic uveal melanoma KF Bol, E Ellebaek, L Hoejberg, MM Bagger, MS Larsen, TW Klausen, ... Cancers 11 (10), 1489, 2019 | 49 | 2019 |
| Therapeutic cancer vaccines in combination with conventional therapy MH Andersen, N Junker, E Ellebaek, IM Svane, P thor Straten BioMed Research International 2010 (1), 237623, 2010 | 47 | 2010 |
| Acquired immune resistance follows complete tumor regression without loss of target antigens or IFNγ signaling M Donia, K Harbst, M van Buuren, P Kvistborg, MF Lindberg, R Andersen, ... Cancer Research 77 (17), 4562-4566, 2017 | 43 | 2017 |
| Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma TH Borch, R Andersen, E Ellebaek, Ö Met, M Donia, IM Svane Journal for ImmunoTherapy of Cancer 8 (2), 2020 | 42 | 2020 |
| Cutaneous adverse reactions to anti–PD-1 treatment—A systematic review AB Simonsen, J Kaae, E Ellebaek, IM Svane, C Zachariae Journal of the American Academy of Dermatology 83 (5), 1415-1424, 2020 | 38 | 2020 |
| mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanoma TH Borch, L Engell-Noerregaard, T Zeeberg Iversen, E Ellebaek, Ö Met, ... Oncoimmunology 5 (9), e1207842, 2016 | 38 | 2016 |
| Immunotherapy for metastatic colorectal cancer: present status and new options E Ellebaek, MH Andersen, IM Svane, PT Straten Scandinavian journal of gastroenterology 47 (3), 315-324, 2012 | 31 | 2012 |
